All Stories

  1. PLGA nanoparticles for nasal drug delivery
  2. Electrospun nanofibers: Exploring process parameters, polymer selection, and recent applications in pharmaceuticals and drug delivery
  3. Comparative Evaluation of the Powder and Tableting Properties of Regular and Direct Compression Hypromellose from Different Vendors
  4. Carrier-Free Inhalable Dry Microparticles of Celecoxib: Use of the Electrospraying Technique
  5. Role of nanostructured lipid carriers in the expression alterations of ATP-binding cassette transporter genes in fluconazole-resistant Candida glabrata
  6. Surface functionalization of lipidic core nanoparticles with albumin: A great opportunity for quinacrine in lung cancer therapy
  7. Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration
  8. An overview of guided tissue regeneration (GTR) systems designed and developed as drug carriers for management of periodontitis
  9. Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension
  10. Loading Pistacia atlantica essential oil in solid lipid nanoparticles and its effect on apoptosis of breast cancer cell line MDA-MB-231
  11. Magnesium Aluminium Silicate-Metformin Hydrochloride Complexes - The Use of Isothermal Calorimetry for Probing Clay and Drug Nanocomplexations
  12. Metronidazole- and Amoxicillin-Loaded PLGA and PCL Nanofibers as Potential Drug Delivery Systems for the Treatment of Periodontitis: In Vitro and In Vivo Evaluations
  13. An investigation of drug compact topography as relates to intrinsic dissolution rates determined by dissolution imaging
  14. Use of thermodynamics in understanding drug release from xanthan gum matrices: The influence of clay-drug complexes
  15. Drug release from magnesium aluminium silicate-polyethylene oxide (PEO) nanocomposite matrices: An investigation using the USP III apparatus
  16. Mechanical and release behaviour of theophylline from matrix tablets containing psyllium powder in combination with grewia polysaccharides
  17. Development of a novel method utilising dissolution imaging for the measurement of swelling behaviour in hydrophilic matrices
  18. A Predictive Integrated Framework Based on the Radial Basis Function for the Modelling of the Flow of Pharmaceutical Powders
  19. Effect of preparation method on the surface properties and UV imaging of indomethacin solid dispersions
  20. Real time calorimetric characterisation of clay – drug complex dispersions and particles
  21. Evaluating the swelling, erosion, and compaction properties of cellulose ethers
  22. Hydro-alcoholic media effects on theophylline release from sesamum polysaccharide gum matrices
  23. The use of various organic solvents to tailor the properties of ibuprofen–glucosamine HCl solid dispersions
  24. Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets
  25. Solid-state, triboelectrostatic and dissolution characteristics of spray-dried piroxicam-glucosamine solid dispersions
  26. Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: A randomized, double-blind, prospective trial
  27. The design of naproxen solid lipid nanoparticles to target skin layers
  28. Drug release from E chemistry hypromellose tablets using the Bio-Dis USP type III apparatus: An evaluation of the effect of systematic agitation and ionic strength
  29. An assessment of triboelectrification effects on co-ground solid dispersions of carbamazepine
  30. Starch-free grewia gum matrices: Compaction, swelling, erosion and drug release behaviour
  31. Triboelectrification and dissolution property enhancements of solid dispersions
  32. Using small-angle X-ray scattering to investigate the compaction behaviour of a granulated clay
  33. Crystal engineering of ibuprofen using starch derivatives in crystallization medium to produce promising ibuprofen with improved pharmaceutical performance
  34. The dissolution and solid-state behaviours of coground ibuprofen–glucosamine HCl
  35. Drug release from matrix tablets: physiological parameters and the effect of food
  36. The influence of salt formation on electrostatic and compression properties of flurbiprofen salts
  37. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices
  38. Aqueous and hydro-alcoholic media effects on polyols
  39. An Investigation into the Stabilization of Diltiazem HCl Release from Matrices Made from Aged Polyox Powders
  40. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices—The use of the USP III apparatus
  41. Psyllium: a promising polymer for sustained release formulations in combination with HPMC polymers
  42. Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling
  43. Release Behaviour of Propranolol HCl from Hydrophilic Matrix Tablets Containing Psyllium Powder in Combination with Hydrophilic Polymers
  44. Effect of ionic strength and pH of dissolution media on theophylline release from hypromellose matrix tablets—Apparatus USP III, simulated fasted and fed conditions
  45. Study of dissolution hydrodynamic conditions versus drug release from hypromellose matrices: The influence of agitation sequence